Received May 12, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | AMVBO72A | — |
expired dose administered; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVBO72A, expiry date 30-APR-2026) for prophylaxis. On 02-MAY-2026, the patient received Menveo. On 02-MAY-2026, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: expired dose administered). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 04-MAY-2026 The pharmacist wanted to know if they need to repeat the dose if the product administered had expired two days earlier.